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Abstract
Background: Human mesenchymal stromal cells (MSCs, also known as mesenchymal stem cells)
are multipotent cells with potential therapeutic value. Owing to their osteogenic capability, MSCs
may be clinically applied for facilitating osseointegration in dental implants or orthopedic repair of
bony defect. However, whether wound infection or oral microflora may interfere with the growth
and osteogenic differentiation of human MSCs remains unknown. This study investigated whether
proliferation and osteogenic differentiation of MSCs would be affected by potent gram-positive and
gram-negative derived bacterial toxins commonly found in human settings.
Results: We selected lipopolysaccharide (LPS) from Escherichia coli and lipoteichoic acid (LTA)
from Streptococcus pyogenes as our toxins of choice. Our findings showed both LPS and LTA did not
affect MSC proliferation, but prolonged LPS challenge upregulated the osteogenic differentiation of
MSCs, as assessed by alkaline phosphatase activity and calcium deposition. Because toll-like
receptors (TLRs), in particularly TLR4 and TLR2, are important for the cellular responsiveness to
LPS and LTA respectively, we evaluated their expression profiles serially from MSCs to osteoblasts
by quantitative PCR. We found that during osteogenic differentiation, MSC-derived
osteoprogenitors gradually expressed TLR2 and TLR4 by Day 12. But under prolonged incubation
with LPS, MSC-derived osteoprogenitors had reduced TLR2 and TLR4 gene expression. This
peculiar response to LPS suggests a possible adaptive mechanism when MSCs are subjected to
continuous exposure with bacteria.
Conclusion: In conclusion, our findings support the potential of using human MSCs as a biological
graft, even under a bacterial toxin-rich environment.
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Mesenchymal stromal cells (MSCs) have been successfully
extracted from bone marrow, muscle, adipose tissue, pla-
centa, and umbilical cord blood [1]. MSCs have also been
found in both human adult dental pulp and exfoliated
deciduous teeth [2-4]. Bone marrow-derived MSCs are
characterized by a high proliferative capacity ex vivo and
can differentiate into a wide variety of mesenchymal pro-
genitor cells under defined culture conditions [5-8]. The
potential therapeutic value of MSCs in regenerative medi-
cine, tissue engineering, and cellular therapy has attracted
substantial interest in recent years [1].
Because MSCs can be induced to differentiate into osteo-
genic tissues [9], their application to modern dentistry
and orthopedic surgery as an alternative to autologous
bone grafts has been explored [2,10]. Accordingly, most
studies focused on using MSCs for in vitro or in vivo tissue
regeneration in the setting of osseointegration of dental
implants or bone grafts for either alveolar bone or long
bone reconstruction [10-13]. However, the human oral
cavity contains a high density of microflora, and dental
implants grafted with MSCs are hence continuously
exposed to different bacterial species and their toxins. In
addition, MSC-aided dental implants or bone grafts might
encounter periodontopathic bacteria-causative agents of
periodontitis. The feasibility of using MSCs in osseointe-
gration by virtue of their differentiation into osteoblasts
depends on whether the growth and osteogenic differen-
tiation of MSCs is affected by bacterial stimuli. Yet, little is
known about the interactions between bacteria and MSCs.
Most studies on this subject focused on the effects of per-
iodontopathic bacteria on osteoclasts, a key cell popula-
tion involved in bacteria-induced bone destruction. Only
a few studies have been done on osteoblasts [14-16] or its
progenitors [17-19], or MSCs [20-22]. Therefore, this
study aimed to investigate the effect of purified bacterial
toxins on the proliferation and osteogenic differentiation
of MSCs.
Streptococcus pyogenes is a gram-positive bacterium that is
commonly found in the human oral cavity; and
Escherichia coli is a gram-negative bacterium that is com-
monly associated with clinical sepsis or occassionally
osteomyelitis [14]. Lipopolysaccharide (LPS) and lipotei-
choic acid (LTA) are bacterial cell-wall components that
are derived from these gram-negative and gram-positive
bacteria, respectively. LPS triggers immune responses such
as proliferation and release of proinflammatory cytokines
from human immune cells. LTA shares with LPS many of
its pathophysiological properties and can thus be consid-
ered as the gram-positive counterpart of LPS but with a
lower mitogenicity [23]. The signaling pathways of these
two bacterial cell-wall components are initiated through
the Toll-like receptors (TLRs) on the surface of immune
cells such as macrophages and dendritic cells. TLRs are
specific receptors that respond to specific pathogen-asso-
ciated molecular patterns on microbial pathogens by acti-
vating innate immune responses and triggering host
defense mechanisms [24,25]. There are at least 11 differ-
ent TLRs found in mammals [25,26]; among them, TLR4
is the major LPS receptor [27], and TLR2 (along with
TLR1/TLR6) is predominantly responsible for recognizing
gram-positive cell-wall structures such as LTA [28].
Although the expression of TLRs has been thoroughly
investigated in immune cells, only several studies in
recent 3 years studied about the gene or protein expres-
sion of TLRs in human bone marrow-derived MSCs
[20,29-32]. Previous studies demonstrated that osteoblas-
tic cells or MSCs express TLR2, TLR4, and other molecules
involved in LPS signaling pathways (Table 1).
In this study, we examined the effects of LPS and LTA on
the proliferation and osteogenic differentiation of MSCs.
Then, we explored TLR2 and TLR4 gene expression pro-
files during the osteogenic differentiation of MSCs with
and without the presence of relevant bacterial toxins.
Table 1: Expression of genes encoding LPS receptor and signaling molecules in osteoblastic cells
Cell type TLR2 TLR4 MD2 CD14 MyD88 References
SaOS-2, HOS, MG-63 - +a + + + [46]
MC3T3-E1 + + NA NA NA [40]
ST-2 + + NA NA NA [40]
SaM-1 cell NA NA NA + NA [47]
Primary mouse + + NA + NA [48]
osteoblasts from + + NA NA NA [40]
embryonic calvaria NA NA NA + NA [49]
+, constitutively expressed; -, not detected; NA, not available.
SaOS-2, HOS, MG-63: human osteosarcoma cell-lines; MC3T3-E1: mouse osteoblastic cell-line; ST-2: mouse stromal cell-line; SaM-1: human 
osteoblastic cell-line from periosteum
TLR2: Toll-like receptor 2; TLR4: Toll-like receptor 4.
a Protein expression of TLR4 was also observed for SaOS-2 only.Page 2 of 12
(page number not for citation purposes)
BMC Cell Biology 2008, 9:52 http://www.biomedcentral.com/1471-2121/9/52Results
LPS and LTA did not induce MSC proliferation
The multipotency of MSCs used in this investigation was
confirmed by standard differentiation assays along three
lineages including osteogenic, adipogenic and chondro-
genic. All the MSCs from the three donors showed similar
differentiating functions. We then tested whether the
MSCs responded to bacterial toxins LPS or LTA. As shown
in Figure 1A, LPS (left panel) and LTA (right panel) did
not affect the proliferation of MSCs during either the 3- or
7-day period, even after incubation with a relatively high
dose of toxin (1 μg/mL of LPS and 10 μg/mL of LTA). As
Effects of LPS and LTA on the proliferation of human MSCs and PBMCsFigure 1
Effects of LPS and LTA on the proliferation of human MSCs and PBMCs. Cultured cells were incubated with either 
LPS (left panel) or LTA (right panel) for 3 days or 7 days. On Day 3 and Day 7, the cell proliferation responses of (A) MSCs and 
(B) PBMCs were assessed by XTT assay respectively. LPS and LTA did not affect the proliferation of MSCs (pooled data from 
three experiments, each done in triplicates) but increased proliferation of PBMCs (one representative experiment done in trip-
licates). The data are expressed as the relative proliferation of untreated controls, mean ± SEM. * P < 0.05; ** P < 0.01; *** P < 
0.001 versus control.Page 3 of 12
(page number not for citation purposes)
BMC Cell Biology 2008, 9:52 http://www.biomedcentral.com/1471-2121/9/52expected, these toxins evoked a marked increase in prolif-
eration of peripheral mononuclear cells (PBMCs) in com-
pared to untreated controls (Figure 1B) (n = 3, P < 0.01).
For the response of PBMCs to bacterial toxins, 1 ng/mL
LPS was sufficient to induce a significant increase in pro-
liferation on Day 3 and Day 7. Since LTA is less potent as
compared to LPS, higher dosages of LTA, 10 ng/mL and
100 ng/mL, were needed to generate a significant response
on Day 7 and Day 3 respectively.
Prolonged LPS challenge enhanced osteogenic 
differentiation of MSCs
To study the effect of bacterial toxins on the osteogenic
differentiation of MSCs, we exposed MSCs with osteogen-
esis-induction medium and toxin for a short-term of 3
days, or prolonged period of either 10 or 14 days as time
points for respective quantitative assays. Alkaline phos-
phatase (ALP) activity was used as an early marker of oste-
ogenic differentiation [33,34]. A period of 3 days was
chosen as the duration for the short-term challenge
because a significant difference in ALP activity between
MSCs with and without osteogenic induction has been
reported previously on Day 4 after osteogenic induction
[9]. Prolonged toxin challenge lasted 10 to 14 days to
allow optimal quantification of MSC osteogenic differen-
tiation by ALP and calcium assays respectively based on
our preliminary studies. Under short-term toxin chal-
lenge, neither LPS at concentrations of 0.1, 1, and 10 μg/
mL (Figure 2A and 2B) nor LTA at 10 μg/mL (Figure 2C
and 2D) had a significant effect on ALP activity or calcium
deposition. After prolonged LPS challenge of higher doses
(1 and 10 μg/mL), ALP activity and calcium levels were
significantly higher than those in untreated controls (n =
3, P < 0.05) (Figure 2A and 2B). In contrast, prolonged
LTA challenge had no effect on ALP activity or calcium
level (Fig 2C and 2D). The increased calcium deposition
after prolonged LPS challenge was further confirmed
semi-quantitatively by von Kossa staining (data not
shown).
Basal levels of TLR4 and TLR2 expression in MSCs were 
low
Because only the osteogenic function but not the prolifer-
ation of MSCs was affected by LPS, we hypothesized that
MSC may not express TLR4 (the major LPS receptor) until
osteogenic differentiation is triggered. We thus evaluated
TLR4 and TLR2 mRNA levels by quantitative PCR. The
constitutive gene expressions of TLR4 and TLR2 on MSCs
were determined using PBMCs as a positive control
because these cells express all TLRs constitutively. As
expected, the basal level of TLR4 mRNA in MSCs was
much lower than that of PBMCs (n = 3, P < 0.05) (Figure
3A). A similar result was observed for the TLR2 mRNA
level, which was virtually undetectable in MSCs (n = 3, P
< 0.01) (Figure 3B).
MSC-derived osteoprogenitors expressed TLR4 and TLR2 
during osteogenesis
When we monitored the expression of TLR4 and TLR2
during MSC osteogenic differentiation, TLR4 mRNA levels
were low during the initial 8 days but increased sharply on
Day 12, by about 9-fold compared to control (n = 3, P <
0.01) (Figure 4A). A similar expression pattern was
observed for TLR2 mRNA levels, with an increase of about
48-fold. (n = 3, P < 0.001) (Figure 4B). Without osteo-
genic induction, TLR2 and TLR4 expression were very low.
LPS challenge downregulated TLR4 and TLR2 expression 
in MSC-derived osteoprogenitors
To determine the effect of LPS on TLR4 expression during
MSC osteogenic differentiation, we exposed MSCs to LPS
(1 μg/mL) under osteogenic conditions. LPS was chosen
for we did not find any effect induced by LTA based on our
result mentioned. The TLR4 and TLR2 mRNA levels were
then determined by quantitative PCR on Day 0, 4, 8, and
12 after osteogenic induction. Under both short-term (3-
day) and prolonged LPS challenge, TLR4 expression of
MSC-derived osteoprogenitors was downregulated signif-
icantly, by about 75%, on Day 12 (n = 3, P < 0.01) (Figure
4C). Surprisingly, even the level of TLR2 expression was
also suppressed by prolonged LPS challenge on Day 12,
by about 67% (n = 3, P < 0.05) (Figure 4D).
Discussion
The increasing interest in using MSCs as a source of cellu-
lar therapy means that the potential impact of bacterial
toxins on the growth and differentiation of MSCs will be
a growing concern. Exposure to endotoxin-enriched envi-
ronment may affect many aspects of MSCs properties such
as self-renewal, differentiation potential, production of
cytokines & ECM compound. Our study focused on the
investigation of the effects of two purified bacteria-derived
toxins on the growth and osteogenic differentiation of
human MSCs. Cell proliferation was not affected by LPS
or LTA, and osteogenic differentiation was promoted by
prolonged exposure to LPS but not to LTA. In addition,
brief exposure to LPS during osteogenic differentiation
reduced the expression of TLR4, whereas prolonged expo-
sure reduced the expression of both TLR4 and TLR2.
Most previous related studies have been conducted on
osteoclasts [35-38], than osteoblasts [14-16] or their com-
mitted progenitors [17-19]. Among the studies related to
the bacterial effects on the osteogenic progenitors, they
used either a 6-day chick periosteal osteogenesis model or
rat calvaria cells, which contain a subpopulation of osteo-
genic precursors. The objectives of these studies were to
find out the possible adverse effects of bacterial toxin on
osteogenesis and they did show bacterial toxin impaired
the osteogensis process. We studied the effect of bacterial
toxins on osteogenic differentiation using human MSCsPage 4 of 12
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of multipotential stem cells. In addition, it is a novel
model comparing to the chick or rat models for it allowed
us to study how bacterial toxins might affect osteogenic
differentiation from MSCs to osteogenic progenitors.
Our study showed that neither LPS nor LTA affected the
proliferation of MSCs, even at relative high endotoxin
doses. This is in line with the findings of previous study by
Hwa Cho et al [29]. We then explored whether these
responses pattern may be related to the expression levels
of TLR4 and TLR2 genes in MSCs. This hypothesis was
partly supported by our observation that very low level of
TLR4 nor TLR2 mRNAs expression levels were detectable
in MSCs. These low TLR4 and TLR2 expression profiles
may serve as a protective mechanism to maintain stem cell
survival from the effect of bacterial toxins, even at high
concentrations. For cellular therapy purpose, this sug-
gested that MSCs could be safely used in clinical settings
even in the microenvironment with bacteria such as oral
surgical sites.
Effects of LPS and LTA on the osteogenic differentiation of MSCsFigure 2
Effects of LPS and LTA on the osteogenic differentiation of MSCs. MSCs were cultured in osteogenesis-induction 
medium and exposed to toxin for 3 days or for the whole incubation period. According to ALP activity and calcium deposition 
assays performed on Day 10 (LPS) or 14 (LTA), short-term LPS challenge did not affect the osteogenic differentiation (A and 
B), but prolonged challenge to 1 and 10 μg/mL upregulated ALP activity and calcium deposition. Neither short-term nor pro-
longed LTA challenge affected the osteogenic differentiation (C and D). The data are from three independent experiments and 
expressed as mean ± SEM. *P < 0.05; ** P < 0.01 versus control.Page 5 of 12
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itors were minimal during early osteogenic induction but
emerged by Day 12. The expression of these two genes
seems to be a natural part of osteoblast differentiation in
the absence of external bacterial stimuli. This finding
agrees with those of previous studies in which osteoblastic
cells and osteoblasts constitutively express TLR4, TLR2,
and other LPS-signaling molecules (Table 1). This is
slightly different from what was observed previously
which showed TLR-2, 3, 4, 6 had a higher expression as
compared to TLR-1, 5, 9, but such differences may be
related to different type of methodology being adopted
[29]. Another study on murine BM-derived MSCs also
showed TLR1 to TLR8 but not TLR9 mRNA was expressed
[30]. Whether such variations in TLRs expression profile
has something to do with the state of differentiation
require further investigation. Although previous studies
examined the basal TLR expression level in MSCs and how
they affect MSC differentiation as we did, our study pro-
vided information on the real time dynamic changes in
the TLR2 and TLR4 mRNA expression profile as they
underwent osteogenic differentiation from MSCs under
the influence of LPS or LTA. Interestingly, LPS but not LTA
could also downregulate the TLR2 and 4 expressions on
Day 12 of differentiation, no matter it was under either
short or prolonged LPS exposure. Our findings suggested
that the TLR2 and 4 expressions could be negatively regu-
lated by endotoxin and such phenomenon has been
described in some immune cells such as monocytes.
When testing whether LPS and LTA affect the osteogenic
differentiation of human MSCs, we found that short-term
challenge by either toxin had no effect, but prolonged LPS
challenge upregulated both ALP activity and calcium dep-
osition. This is in line with the findings of Hwa Cho et al.
who found an increase in the osteogenic marker genes
expression such as the ALP, osteopontin and BMP2 at the
5th and 10th day after induction [29]. We confirmed such
findings by measuring the ALP protein level on Day 10.
Documented effects of E. coli LPS on osteoblastic cells are
mixed. No inhibitory effect of E. coli LPS were found on
osteoblastic cell line MC3T3-E1 and rat calvaria cells
[17,39]. However, Shjoi et al. found an inhibitory effect
on ALP activity of SaOS-2, an osteoblast-like osteosar-
coma cell line [15]. Factors contributing to discrepancies
in results may include heterogeneity of the cell source, the
experimental conditions, and the culture system used. For
TLR2 ligands, it has been shown that PGN stimulated the
osteogenic differentiation of human adipose-derived
MSCs in a dose-dependent manner similar to that of LPS
[29]. However, no such effect was found concerning LTA
used in our study on BM-derived MSCs. Why LPS and LTA
affect the MSC differentiation differently in our study
remains to be answered, but the specificity and potency of
different ligands on the TLRs and also the involvement of
different signaling pathways may account for such varia-
tions [20,30-32].
In this study, the effects of LPS exposure during MSC oste-
ogenic differentiation depended on the duration of expo-
sure. This finding might be explained partly by the
kinetics of TLR4 gene expression: the lack of an effect from
short-term LPS challenge might be due to the delay in
expression of TLR4. Therefore, the timing of the activation
of TLR genes may play an essential role in altering the
TLR4 and TLR2 constitutive gene expression in MSCs and PBMCsFigure 3
TLR4 and TLR2 constitutive gene expression in 
MSCs and PBMCs. Quantitative PCR revealed that consti-
tutive expression of (A) TLR4 was higher in PBMCs than in 
MSCs, while (B) TLR2 was not expressed in MSCs. The data 
are pooled from three experiments, each done in duplicates, 
and expressed as mean ± SEM. * P < 0.05; ** P < 0.01.
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finding may explain why studies using osteoblasts and
osteogenic precursor cells as effector cells can yield differ-
ent results after bacterial challenge.
On the other hand, since osteogenic differentiation of
MSCs was promoted by prolonged LPS challenge, we fur-
ther examined whether constitutive TLR gene expression
on osteoprogenitors was also affected by LPS. Interest-
TLR gene expression of MSCs at basal state and under osteogenic differentiation with and without LPS exposureFigur  4
TLR gene expression of MSCs at basal state and under osteogenic differentiation with and without LPS expo-
sure. (A) Quantitative PCR revealed that TLR4 expression was significantly higher after 12 days of incubation in osteogenesis-
induction medium than after shorter periods, and higher than after 12 days of constitutive expression. (B) Quantitative PCR 
revealed that TLR2 expression in MSCs was significantly higher after 12 days of incubation in osteogenesis-induction medium 
than after shorter periods, and higher than after 12 days of constitutive expression. (C) TLR4 expression in MSCs cultured 
under osteogenic conditions was lower on Day 12 after exposure to LPS (1 μg/mL) for 3 or 12 days. (D) TLR2 expression in 
MSCs cultured under osteogenic conditions was lower on Day 12 after exposure to LPS (1 μg/mL) for 12 days, but not after 3-
day LPS exposure. The data are pooled from three experiments, each done in duplicates, and expressed as mean ± SEM. * P < 
0.05; ** P < 0.01; *** P < 0.001.
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genes was downregulated in osteoprogenitors after con-
tinuous LPS exposure. Little has been reported on how
bacterial toxins regulate the expression of TLRs on osteob-
lastic cells. One study [40] showed an immediate effect of
LPS challenge on TLR2 and TLR4 expression of primary
murine osteoblasts and MC3T3-E1 cells; unexpectedly,
TLR2 but not TLR4 mRNA was upregulated within two
hours of E. coli LPS exposure. This raised a question about
the specificity of TLRs and some degree of crosstalk
between TLR2 and TLR4 may actually exist. In our experi-
ments, prolonged toxin exposure was designed to mimic
the situation in which MSCs interact continuously with
oral microflora or with bacterial toxins during chronic
inflammatory bone disease. Our results suggested that
MSC-derived osteoprogenitors could adapt to continuous
LPS challenge by reducing TLR4 and TLR2 expression,
thereby they can be spared from the toxic effect of these
toxins, leading to a paradoxical upregulation of osteo-
genic activities.
A similar adaptive response phenomenon, known as
"endotoxin tolerance," can be found in monocytes and
macrophages [41]. Endotoxin tolerance has been well
documented as a cell-desensitizing phenomenon that
results from sustained exposure of sublethal doses of LPS,
which leads to a reduced capacity of the host (in vivo) or
of macrophages (in vitro) to further respond to LPS [42].
Furthermore, TLR4 expression on the surface of LPS-toler-
ant macrophages has been shown to be downregulated
[42], which may account for the molecular mechanism of
endotoxin tolerance. Therefore, we suggest that MSC-
derived osteoprogenitors acquire an adaptive tolerance
under continuous LPS exposure in order to prevent exces-
sive bone and tissue destruction, thereby protecting or
preserving the host organ tissues.
Endotoxin tolerance can be found in oral mucosa cells
and is associated with chronic periodontitis [43]. In addi-
tion, TLR2 and TLR4 mRNAs are significantly downregu-
lated in the gingival tissue of patients with chronic
periodontitis as compared to healthy persons [43], sug-
gesting that the oral mucosa develops endotoxin tolerance
in chronic periodontitis. Although experimental endo-
toxin tolerance involves prior incubation of LPS before
subsequent challenge, a study of human gingival fibrob-
lasts-a major constituent of gingival connective tissue that
interacts directly with bacteria in periodontitis-has shown
that TLR4 expression can be downregulated by LPS with-
out prior LPS incubation [44]. Whether osteoprogenitors
or osteoblasts indeed display endotoxin tolerance
remains to be confirmed. Interestingly, we also observed
downregulation of TLR4 gene expression after osteogenic
induction in MSCs that had undergone short-term LPS
challenge. These data may suggest that gene might be
switched off in the early phase of osteogenic differentia-
tion. Finally, the paradoxical puzzle of inhibition of the
TLR receptor expression by LPS was not contradictory to
the positive effect on osteogenic differentiation remained
to be solved. Possible explanation may include the pres-
ence of alternated receptor and signaling pathway for LPS
induced osteogenesis.
Conclusion
In conclusion, we found that MSCs initially express very
low levels of TLR2 and TLR4, but MSC-derived osteopro-
genitors acquire these receptors. Such dynamic changes
may at least partly explain why osteoblasts become
responsive to LPS after an early critical stage of osteogenic
differentiation. More importantly, MSC-derived osteopro-
genitors adapt by reducing TLR4 and TLR2 expression
after exposure to LPS during osteogenic differentiation.
This adaptive response suggests that an intrinsic regula-
tory mechanism maintains homeostasis in tissues that
persistently interact with microbial flora such as in the
oral mucosa or infected tissue. These findings support the
potential of using human MSCs as a biological graft, even
in a bacterial toxin-rich environment. However, it is still
not clear from our data that whether other properties of
MSCs such as cytokine release, cell adhesion, etc. are
affected by exposure to endotoxins and further works are
needed to clarify on these aspects.
Methods
Isolation and culture of human MSCs
This study was approved by the Joint Ethics Committee
(Internal Review Board) of The University of Hong Kong
and the Hospital Authority Hong Kong West Clusters. The
culture conditions, immunophenotyping, and assays for
confirming the differentiating functions of human MSCs
have been described previously [45]. Briefly, bone mar-
row samples were collected from three young healthy
adult bone marrow donors. All MSCs were only used
within 3–6 passages. Heparinized bone marrow samples
were mixed with twice their volume of phosphate-buff-
ered saline (PBS) and were separated in Ficoll-Hypaque
density gradient (Amersham Biosciences, Uppsala, Swe-
den). Mononuclear cells were collected from the interface
and washed twice with PBS. The washed cells were resus-
pended in MSC medium, which consisted of low-glucose
Dulbecco's modified Eagle medium (DMEM; Invitrogen,
Carlsbad, CA), 10% fetal bovine serum (FBS; Hyclone,
Logan, UT), 100 U/mL penicillin, 100 mg/mL streptomy-
cin, and 2 mM L-glutamine (Invitrogen). The cells were
plated at 5 to 30 × 106cells in 100-mm2 culture dishes.
Cultures were maintained at 37°C in a humidified atmos-
phere containing 5% CO2. After 24 h, nonadherent cells
were removed and the adherent cells were washed twice
with PBS. The culture medium was replaced every three to
four days. When the cultures approached confluence, cellsPage 8 of 12
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mM EDTA (Invitrogen) and replated at a density of 2 ×
105 cells in 75-cm2 culture flasks. By using flow cytometry,
all the MSCs used in the studies have standard MSCs
immunophenotypes with positive for CD29, CD105,
CD73, CD90 and MHC class I; negative for CD45, CD34,
CD14, CD19 and MHC class II.
Isolation and culture of human peripheral blood 
mononuclear cells
PBMCs were used as a positive control and were isolated
from the buffy coat derived from blood taken from
healthy voluntary donors. The buffy coat was diluted with
PBS and separated in a Ficoll-Hypaque gradient density.
Mononuclear cells were collected from the interface and
washed twice with PBS. The washed cells were resus-
pended in RMPI 1640 medium that was supplemented
with 10% FBS, 100 U/mL penicillin, and 100 mg/mL
streptomycin. Cultures were maintained at 37°C in a
humidified atmosphere containing 5% CO2.
Cell proliferation assay
The effects of LPS and LTA on MSCs and PBMCs prolifer-
ation were measured using Cell Proliferation Kit II XTT
assay kit (Roche Molecular Biochemicals, Mannheim,
Marburg, Germany), which was based on the mitochon-
drial activity of metabolic active cells, according to the
manufacturer's instructions. The findings were further cor-
related with cell counting. Briefly, cells were grown in flat-
bottomed 96-well plates in a final volume of 100 μL of
culture medium per well. LPS from E. coli O111:B4 or LTA
from S. pyogenes (Sigma, St. Louis, MO) were then added
to the culture medium at different concentrations (LPS, 1
ng/mL-1 μg/mL; LTA, 1 ng/mL-10 μg/mL) for 3 or 7 days
for XTT assay. After the incubation period, 50 μL of the
XTT labeling mixture was added to each well and incu-
bated for 4 h at 37°C in a humidified atmosphere con-
taining 5% CO2. The spectrophotometric absorbance was
measured at 450 nm, and results were normalized against
that of untreated MSCs and expressed as the relative pro-
liferation (%).
Differentiation of MSCs
The capacity of MSCs to differentiate along osteogenic
and adipogenic lineages was assessed as previously
reported [5-8]. For the induction of MSC osteogenic dif-
ferentiation, the cells were treated with osteogenesis-
induction (OS) medium, which was DMEM containing
10% FBS, 50 μM L-ascorbic acid-2-phosphate, 10 mM β-
glycerol phosphate, and 100 nM dexamethasone (Sigma,
St. Louis, MO). Differentiation was monitored with alka-
line phosphatase (ALP) and calcium spectrophotometric
assays; ALP activity and calcium deposition were also
tested by ALP staining and von Kossa staining.
For the induction of MSC adipogenic differentiation, con-
fluent MSC cultures were induced to undergo adipogenic
differentiation by culturing cells in adipogenesis-induc-
tion (MDI+I) medium, which was DMEM containing 1
μM dexamethasone, 10% FBS, 0.5 mM methyl-isobutylx-
anthine, 10 μg/mL insulin, and 100 μM indomethacin,
100 U/mL penicillin, and 100 mg/mL streptomycin
(Sigma). After 48 to 72 h, the medium was changed for 24
h to adipogenesis-maintenance (AM) medium, which was
DMEM containing insulin (10 μg/mL), 10% FBS, 100 U/
mL penicillin, and 100 mg/mL streptomycin (Sigma). The
MSCs were then retreated with MDI+I and AM medium
alternately for two more cycles. The cells were stained with
Oil Red O to reveal the extent of lipid accumulation.
For the induction of MSC chondrogenic differentiation,
aliquots of 2 × 105 cells in a 15 mL centrifuge tube were
centrifuged at 800 rpm for 5 min at room temperature.
The pellet was resuspended in chondrogenesis-induction
medium, which was DMEM high glucose containing 10
ng/mL recombinant human transforming growth factor
beta 3 (rhTGF-β3), 100 nM dexamethasone, 6 mg/mL
insulin, 100 mM ascorbic acid 2-phosphate, 1 mM
sodium pyruvate, 6 mg/mL transferrin, 0.35 mM praline
Table 2: DNA sequences of primers used in quantitative PCR analysis
Gene Sequence
β-actin (F) GGA TGC AGA AGG AGA TCA CTG
(R) CGA TCC ACA CGG AGT ACT TG
(P) CCC TGG CAC CCA GCA CAA TG
TLR2 (F) TGT GAA GAG TGA GTG GTG CAA GT
(R) ATG GCA GCA TCA TTG TTC TCA T
(P) TGA ACT GGA CTT CTC CCA TTT CCG TCT TT
TLR4 (F) CAC TCG ATG TCA TTC CAA AGT TAT TG
(R) AGA GTG CCC CCT TTA AAC AAA TT
(P) TAC TAA GTA ATG ACT GTC ATG AAA GCA GCA T
F, forward primer; R, reverse primer; P, Taqman probe.
TLR2, Toll-like receptor 2; TLR4, Toll-like receptor 4Page 9 of 12
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were then centrifuged as pellet and maintained for 3
weeks with regular induction medium replacement every
2 days. At the end of the incubation, pellets were fixed and
processed for 5 μM thick paraffin sections for Alcian blue
staining.
Exposure of MSCs to bacterial toxins under osteogenic 
conditions
MSCs were plated in MSC medium at 2 × 103 cells/cm2 in
6 well-plates. On the following day (Day 0), the cells were
incubated with osteogenesis-induction (OS) medium and
toxins. The concentrations of LPS (0.1, 1, and 10 μg/mL)
and LTA (10 μg/mL) used were based on preliminary data.
Incubation with bacterial toxin was either short-term (3-
day) or continuous until specific endpoints for quantifica-
tion of osteogenic differentiation. After the short-term
exposure to bacterial toxins, the cells were washed and
replaced with culture medium. All cells (either for short-
term or prolonged exposure to toxins) will be subjected to
the determination of alkaline phosphatase (ALP) activity
on Day 10 and calcium deposition on Day 14. The
medium and toxin were replaced every 3 day.
ALP assay
On Day 10 after osteogenic induction in the presence or
absence of toxins, an ALP assay was performed colorimet-
rically using a Liquicolor kit (Stanbio Laboratory, Boerne,
TX). To prepare the cell lysates, cell layers were washed
twice with PBS and then extracted with 1% Triton X-100
(v/v, in water) by shaking overnight at 4°C. ALP enzyme
activity was calculated after spectrophotometrically meas-
uring the absorbance at 405 nm of p-nitrophenol product
that formed at 37°C. ALP activity was defined as the
amount of enzyme that produced 1 mM of p-nitrophenol
per minute. Results were recorded as ALP activity per mil-
ligram of total cell protein.
Calcium assay
On Day 14 after osteogenic induction in the presence or
absence of toxins, cell layers were rinsed twice with PBS
and scraped off in 0.5 M HCl. The cell layers were
extracted by shaking overnight at 4°C and then centri-
fuged at 1000 × g for 5 min. The supernatant was used for
calcium level determination according to the manufac-
turer's instructions using a Liquicolor kit (Stanbio Labora-
tory). Calcium deposition was determined by absorbance
measured spectrophotometrically at 630 nm; standards
were prepared in parallel. Results were expressed as
amount of calcium (μg) per milligram of total cell pro-
tein.
Determination of TLR4 and TLR2 mRNA levels
To study TLR4 and TLR2 gene expression profiles of MSCs
with and without osteogenic induction, we collected RNA
on Day 0, 4, 8, and 12 with and without OS medium.
MSCs under osteogenic conditions were also exposed to
either short-term (3-day) or continuous challenge to toxin
until sample collection. After the initial 3-day exposure to
bacterial toxins, the cells were washed and replaced with
conventional culture medium. Based on the previous
results, LTA had no effect and therefore 1 μg/mL of LPS
was chosen. Total cellular RNA was extracted from cul-
tured cells using TRIzol (Invitrogen) according to the
manufacturer's instructions. Reverse transcription was
performed on the DNase I-treated RNA using random
hexamers and RNase H- Superscript II reverse tran-
scriptase (Invitrogen) according to the manufacturer's rec-
ommendation. The cDNA that was synthesized was
subjected to PCR amplification, and the PCR product was
quantified by real-time PCR using the Taqman fluores-
cence kit (Applied Biosystems, Foster City, CA). The prim-
ers that were used are shown in Table 2. The β-actin gene
was amplified as an internal control. Standard curves were
generated using serial dilutions of plasmids (~10–107
copies) containing the cloned sequences involved. To
standardize the results for variability in RNA and cDNA
quantity and quality, the results were converted to the
number of target copies per 105 copies of β-actin gene.
Statistical analysis
All data are expressed as mean ± standard error of the
mean. Differences between groups were analyzed by
paired Student t tests or one-way ANOVA. A P value of <
0.05 was considered to be significant.
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